Atlas Trials

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Clinical trial NCT03325127 · WITHDRAWN

Trial details

NCT number
NCT03325127
Sponsor
Bayer
Status
WITHDRAWN
Study type
OBSERVATIONAL
Prostatic Neoplasms, Castration-Resistant
Start date
2017-10-30
Primary completion
2018-09-28
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.